In order to clear up the issue, we have investigated a large series of patients with a long follow-up, using a retrospective multicentric study (894 breast cancers T1-T2, N0-N1, M0; median follow-up: 67 months). PTKs were measured using a radioenzymatic assay as described in our ...
ultrasound, magnetic resonance imaging and combinations of these imaging modalities for the detection of small (≤2 cm) breast cancer[J]. Medicine (Baltimore), 2021, 100(26): 526-531. DOI: 10.1097/md.0000000000026531.
因此,对于年轻、有保乳意愿的HER2阳性乳腺癌患者,推荐接受曲妥珠单抗联合帕妥珠单抗的双靶新辅助治疗方案,有望达到pCR,实现保乳目标。 此病例中的患者38岁,为未绝经女性,2019年2月21日,诊断为左乳浸润性导管癌(cT2N1M0,IIB期,HER2阳性型)...
This is a retrospective study of the results of various types of surgical treatment of early breast cancer staged histologically using the following characteristics: (1) poor cytologic differentiation, (2) lymphatic permeation, (3) blood vessel invasion, or (4) invasion of the tumor into the surr...
davg 1 (nm) aav 2 (nm) ξavg 3 (mV) Surface Coating Amount (wt%) TGA EA M 4 at 2.0 T (emu/g) r1 5 r2 6 (s−1mM−1) (s−1mM−1) r2/r1 λabs-max 7 (nm) λem-max 8 (nm) η9 (%) P3h.a0r±m0a.c1eutic2a2l0s..412±020, −40.0 ± 13,0.x2 FOR...
Triple-negative breast cancer (TNBC) is highly aggressive and insensitive to conventional targeted therapies, resulting in poor therapeutic outcomes. Recent studies have shown that abnormal iron metabolism is observed in TNBC, suggesting an opportunity for TNBC treatment via the iron-dependent Fenton reac...
Breast Cancer Res. Treat. 1996, 39, 327-334.Bolla M, Rostaing-Puissant B, Bottari SP, Chedin M, Marron-Charrière J, Colonna M, Berland E, Chambaz EM: Protein tyrosine kinase activity in 350 T1-T2, N0-N1 breast cancer: preliminary results. Breast Cancer Res Treat 39: 327–334, ...
Protein tyrosine kinase activity in 350 T1/T2, N0/N1 breast cancer. Preliminary results. Breast Cancer Res. Treat. 1996, 39, 327-334.Bolla M, Rostaing-Puissant B, Bottari AP et al. Protein tyrosine kinase activity in 350, T1/T2, N0/N1 breast cancer. Preliminary results. Br. Cancer Res...
From 1982 to 1990, 695 women less than 75 years, without any previous or synchronous carcinoma, suffering from an invasive breast cancer classified as TI T2/N0 N1/M0 according to clinical TNM staging, were enrolled in this study. 82.4% underwent a breast conservative procedure and 17.2% a ...
诊断:右侧乳腺癌 pT2N1M0 IIB期 Luminal B型 术后辅助治疗方案 2018-11-19 予EC*4-T*4方案化疗。 2019-5-10起 行辅助放疗。 后口服枸橼酸托瑞米芬片(法乐通)内分泌治疗。 治疗过程 一线治疗 2022-07-10 B超提示:肝内多发结节,(转移可能不除外)。